House Panel Criticizes F.D.A. Role in Drug Cases - New York Times

House Panel Criticizes F.D.A. Role in Drug Cases - New York Times: "House members chastised the Food and Drug Administration on Tuesday for not doing more inspections of foreign drug manufacturers in the wake of a litany of problems with the blood thinner heparin and other products."